📰 Linkedin Invitae News
Page 3 - Linkedin Invitae News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Linkedin Invitae. Real-time updates on events, politics, business and more.
April 17, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today published its 2023 Environmental, Social and Governance (ESG) Report. This...
April 13, 2023
– Highlights the use of Invitaes personalized cancer monitoring technology to correlate clinical outcomes with minimal residual disease presence – – The analysis demonstrates... | April 13, 2023
March 21, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced its partnership with Epic, an industry-leading healthcare software...
March 16, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of W. Michael Korn, M.D., as its chief medical...
March 15, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced seven studies, including one oral presentation and six posters, to be...
March 6, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that its Personalized Cancer Monitoring (PCM™) assay, which helps...
March 1, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight, president and chief executive officer, will...
February 28, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it has signed exchange and financing agreements with a fund...
February 28, 2023
– Entered into a ~$336 million transaction for the 2024 convertible notes, effectively addressing ~96% of the amount outstanding (see separate press release to...
January 30, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, has announced that aerospace, transportation and industrial supplies veteran William...